We are working to understand human metabolism and what happens when this biological system breaks down. The problem is more important than ever, given the increasing burden that diabetes and other metabolic dysfunctions have on human health and society.

First immune-evading cells created to treat type 1 diabetes

Professor Ronald Evans, first author and former Staff Scientist Eiji Yoshihara, and colleagues have made a major advance in the pursuit of a safe and effective treatment for type 1 diabetes. Using stem-cell technology, they generated the first human insulin-producing pancreatic cell clusters able to evade the immune system. These “immune shielded” cell clusters controlled blood glucose without immunosuppressive drugs in mice, once transplanted in the body.

Sign up for our monthly newsletter.

Latest discoveries, events & more.